BPC-157 / thymosin alpha-1 stack: what's in it

The short answer

BPC-157 / thymosin alpha-1 stack combines BPC-157 and Thymosin alpha-1.

The parts

  • BPC-157 Index

    Not FDA-approved · advisory vote July 2026 · no FDA decision

    WADA 2026: S0

    BPC-157
    Papers on animals103
    Lab-dish (cell) papers1
    Papers PubMed tags as about people55
    Registered trials (ClinicalTrials.gov)2 of 3 search results name BPC-157
    Randomized trials in peoplenone found
  • Thymosin alpha-1 Index

    Approved outside the US

Bars are counts of papers or trials; a longer bar means more studies, not better results. Study counts auto-counted from PubMed tags and ClinicalTrials.gov in the Ellum research database, as of October 6, 2026 (not reviewed; a paper can carry more than one tag). Papers PubMed tags as about people: includes reviews and case reports; not randomized trials. All bars share one scale. Each count is for that part alone.

Regulatory status by component

Not FDA-approved How we label status

  • As of October 4, 2026, BPC-157 is not FDA-approved. On July 23, 2026, FDA's compounding advisory committee voted to recommend adding it to the 503A bulks list; FDA staff had recommended against it. FDA has not proposed that change. See BPC-157 in the Index →
  • As of October 4, 2026, Thymosin alpha-1 is not FDA-approved for any use and is not on FDA's 503A bulks list. It is approved in Italy. See Thymosin alpha-1 in the Index →

Status as of October 4, 2026

As a combination
No category as a combination (see components)
  • BPC-157: as of October 4, 2026 · source
  • Thymosin alpha-1: as of October 4, 2026 · source

Get updates on BPC-157 / thymosin alpha-1 stack

We'll store your email, your state, the page you're on and the peptides selected below (pre-selected from this page; untick any). Together these can reveal health interests. We use them only for what you tick below and to count sign-ups by state and peptide, without emails, to plan where the clinic opens and for reports that show only totals. Our hosting, database and email providers handle them for us. We pass them to a doctor or clinic only if you tick that box, and we don't sell them. Withdraw anytime with the unsubscribe link or at hello@ellumclinic.com. Consumer Health Data Privacy Policy

Ellum's sign-ups are for adults 18 and over.

Peptides: BPC-157 / thymosin alpha-1 stack (1 selected) · edit
Peptides you're interested in
What we may email you about
More options (optional): research, doctor contact, paid offers

The research on BPC-157 / thymosin alpha-1 stack

Key facts

Also known as: bpc-157 thymosin alpha-1, bpc ta1

Parts
BPC-157 and Thymosin alpha-1
Route
injectable;oral

References

Status sources

Sources as of October 4, 2026

  1. FDA: www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
  2. FDA: api.fda.gov/drug/drugsfda.json

What this doesn’t establish

Results for one compound don't tell you what the two do together.